Nachrichten zur Illumina Inc. Aktie

Illumina Confirms Joydeep Goswami As New CFO

SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN), a DNA sequencing and array-based technologies firm, announced Wednesday that Joydeep Goswami has…

Joydeep Goswami is the new finance chief of Illumina

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina Appoints Joydeep Goswami Chief Financial Officer

SAN DIEGO, Feb. 1, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies,…

Illumina: Video: UK Festival of Genomics & Biodata Inspires and Connects Genomics Leaders

NORTHAMPTON, MA / ACCESSWIRE / January 31, 2023 / IlluminaOriginally published on Illumina News CenterThe Festival of Genomics & Biodata…

Illumina downgraded to hold at Argus on poor near-term outlook

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina: Kursziel reduziert

Vancouver (www.aktiencheck.de) - Rating-Update: Kyle Mikson, Analyst von Canaccord Genuity, bewertet die Aktie des Sequenzierungsspezialisten Illumina Inc. (ISIN: US4523271090, WKN:…

Illumina CEO on Earnings Outlook, Buying Grail

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina facing huge fine from EU over closing GRAIL deal without antitrust approval

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Exclusive-Illumina to face EU fine of 10% of turnover over Grail deal -sources

...By Foo Yun Chee BRUSSELS (Reuters) - U.S. life sciences company......…

Insiderhandel: SVP, Chief Commercial Officer verkauft Aktien von Illumina im Wert von 102.290$

Tousi, Susan H. - Vorstand - Tag der Transaktion: 2023-01-06...…

Illumina to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023

SAN DIEGO, Jan. 10, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the fourth…

Why Illumina Has Grown Cautious and What It Means for the Stock

The gene-sequencing company grew sensationally during the pandemic, but sales moderated in the second half of 2022. Now it expects…

UPDATE 1-Illumina challenges EU order to keep Grail separate

... (Reuters) - U.S. life sciences company Illumina on Tuesday challenged......…

Illumina challenges EU order to keep Grail separate

...By Foo Yun Chee BRUSSELS (Reuters) - U.S. life sciences company......…

Illumina Plunges 16% on Weaker-Than-Expected 2023 Profit Outlook

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina, Amgen to genome sequence 35K DNA samples

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina and Nashville Biosciences Announce Sequencing Agreement with Amgen

Whole-genome sequencing of 35,000 de-identified, diverse genomic DNA samples will begin this month SAN DIEGO, Jan. 9, 2023 /PRNewswire/ --…

Illumina: Coverage-Aufnahme

Toronto (www.aktiencheck.de) - Rating-Update: Sung Ji Nam, Analyst der Scotiabank, nimmt die Coverage der Aktie von Illumina Inc. (ISIN: US4523271090,…

Form 8-K ILLUMINA, INC. For: Jan 04

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Are Options Traders Betting on a Big Move in Illumina (ILMN) Stock?

Investors need to pay close attention to Illumina (ILMN) stock based on the movements in the options market lately....…

Illumina To Webcast Upcoming Investor Conference

SAN DIEGO, Dec. 19, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at…

Cancer researchers question antitrust arguments against Illumina-Grail deal

...By Deena Beasley and Julie Steenhuysen LOS ANGELES/CHICAGO (Reuters... competing test developers need to thrive. But Reuters interviews......…

FOCUS-Cancer researchers question antitrust arguments against Illumina-Grail deal

... (Reuters) - U.S. and European antitrust enforcers want to unwind gene... the technology competing test developers need to thrive. But Reuters interviews......…

Illumina-Aktie: Besteht noch Hoffnung für Anleger?

Die Illumina-Aktie (WKN: 927079) hat seit Mitte 2021 eine schlechte Performance abgeliefert. Sie hat sich gegenüber dem damaligen Kurs mehr…

Is Illumina Cheap or Expensive?

It depends on which numbers you focus on....…

Illumina Ranks Among Top Scores on Dow Jones Sustainability Index and CDP

As of December 9, 2022 Illumina awarded highest score from S&P Dow Jones Indices in Life Sciences Tools & Services…

Illumina defends $7.1 billion Grail buy to fend off antitrust regulators

...By Diane Bartz WASHINGTON (Reuters) - U.S. life sciences company......…

Illumina defends $7.1 bln Grail buy to fend off antitrust regulators

...By Diane Bartz WASHINGTON, Dec 13 (Reuters) - U.S. life sciences......…

Insights on the NGS Kits Global Market to 2032 - Featuring Agilent Technologies, BGI, Hologic, Illumina, New England Biolabs and Takara Bio Among Others

DUBLIN, Dec. 13, 2022 /PRNewswire/ -- The "NGS Kits Market - A Global and Regional Analysis: Focus on Workflow, Sequencing…

Illumina: Downgrade

New York (www.aktiencheck.de) - Rating-Update: Patrick Donnelly, Analyst der Citigroup, stuft die Aktie von Illumina Inc. (ISIN: US4523271090, WKN: 927079, Ticker-Symbol…

Insiderhandel: SVP, Chief Commercial Officer verkauft Aktien von Illumina im Wert von 106.315$

Tousi, Susan H. - Vorstand - Tag der Transaktion: 2022-12-06...…

UPDATE 1-EU charge sheet tells Illumina to swiftly unwind Grail deal

... (Reuters) - EU antitrust regulators on Monday proposed measures for U.S......…

EU charge sheet tells Illumina to swiftly unwind Grail deal

...By Foo Yun Chee BRUSSELS (Reuters) -EU antitrust regulators on Monday......…

EU Tells Illumina How to Unwind Deal to Buy Cancer-Test Developer Grail

The European Commission said Illumina will have to restore Grails independence and return it to the same level that existed…

European Commission Informs Illumina of Restorative Measures Over Grail Acquisition

European Commission Informs Illumina of Restorative Measures Over Grail Acquisition...…

Form 8-K ILLUMINA, INC. For: Nov 29

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

NGS-Based RNA-Sequencing Global Market Report 2022: Ukraine-Russia War Impact

NEW YORK, Nov. 30, 2022 /PRNewswire/ -- Major players in the ngs-based rna-sequencing market are Illumina, Thermo Fischer Scientific, Oxford…

Genotek (Yerevan, Armenia), Professor Tamara Sarkisian and Illumina open a world-class genomic laboratory

Yesterday, the genetic laboratory Genotek started to work in Yerevan, Armenia. The main goal is to provide the people of…

Illumina To Webcast Upcoming Investor Conferences

SAN DIEGO, Nov. 15, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at…

Illumina to shed 5% of global headcount

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina cuts 5% of its workforce

...(Reuters) - Illumina Inc said on Monday it was cutting 5% of its......…

UPDATE 1-Illumina cuts 5% of its workforce

...(Adds details on costs, background) Nov 14 (Reuters) - Illumina Inc......…

Insiderhandel: SVP, Chief People Officer verkauft Aktien von Illumina im Wert von 289.403$

Hoyt, Aimee L. - Vorstand - Tag der Transaktion: 2022-11-07...…

Insiderhandel: SVP, Chief Commercial Officer verkauft Aktien von Illumina im Wert von 111.825$

Tousi, Susan H. - Vorstand - Tag der Transaktion: 2022-11-07...…

Insiderhandel: SVP, Chief Technology Officer verkauft Aktien von Illumina im Wert von 78.698$

Aravanis, Alexander - Vorstand - Tag der Transaktion: 2022-11-08...…

11 Analysts Have This to Say About Illumina

Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following analyst ratings: Latest Ratings for ILMN DateFirmActionFromTo…

Illumina (ILMN) Surpasses Q3 Earnings and Revenue Estimates

Illumina (ILMN) delivered earnings and revenue surprises of 17.24% and 1.33%, respectively, for the quarter ended September 2022. Do the…

Illumina Q3 Profit Beats Street View, But Cuts FY Outlook

SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN) Thursday reported third-quarter net loss of $3.82 billion or $24.26 per share, compared…

Illumina slips as GRAIL impairment prompts guidance cut

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Should You Buy Illumina (ILMN) Ahead of Earnings?

Illumina (ILMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…